A Diagnostic Leader in personalized onco-medicine

Providing High-Quality Gene Expression Prognostic & Predictive Services for the Personalized Medicine
arena to Enable Better Management of Cancer Patients

Company

Scientific Consultants

Daniel Notterman, M.A., M.D.

Joseph Aisner, M.D.  

 John Langenfeld, M.D.

Judith Amorosa, M.D.